RXMD receives New York Pharmacy License!
http://finance.yahoo.com/news/progressive-car...50274.html
MIAMI, FL--(Marketwired - April 15, 2016) - Progressive Care Inc. (OTC PINK: RXMD), through its subsidiary Pharmco LLC, a South Florida health services organization and provider of prescription pharmaceuticals specializing in health practice risk management, compounded medications, the sale of anti-retroviral medications and related medication therapy management, and the supply of prescription medications to long term care facilities, announces the receipt of its New York State Pharmacy license.
On April 4, 2016, the state of New York granted a non-resident pharmacy license to PharmCo, LLC. The license is effective until March 31, 2019 and allows PharmCo to dispense both traditional medications and compounds to residents of New York. The Company plans to market its products and services and ship medications from its North Miami Beach facility.
"We are thrilled to receive this new license," stated S. Parikh Mars, CEO. "New York is the first of many licenses we hope to receive in the near future. We currently have applications pending in another 4 states and will be submitting more applications in the coming months. This is a significant step to expanding nationally and we believe that we will be able to see the results of our expansion before the end of the year."
About Progressive Care
Progressive Care, Inc. (OTC PINK: RXMD), through its subsidiary PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals specializing in health practice risk management, compounded medications, the sale of anti-retroviral medications and related medication therapy management, and the supply of prescription medications to long term care facilities.
Cautionary Statement Regarding Forward Looking Statements
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company's expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words "anticipate," "believe," "estimate," "upcoming," "plan," "target", "intend" and "expect" and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company's actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.
http://finance.yahoo.com/news/progressive-car...50274.html
MIAMI, FL--(Marketwired - April 15, 2016) - Progressive Care Inc. (OTC PINK: RXMD), through its subsidiary Pharmco LLC, a South Florida health services organization and provider of prescription pharmaceuticals specializing in health practice risk management, compounded medications, the sale of anti-retroviral medications and related medication therapy management, and the supply of prescription medications to long term care facilities, announces the receipt of its New York State Pharmacy license.
On April 4, 2016, the state of New York granted a non-resident pharmacy license to PharmCo, LLC. The license is effective until March 31, 2019 and allows PharmCo to dispense both traditional medications and compounds to residents of New York. The Company plans to market its products and services and ship medications from its North Miami Beach facility.
"We are thrilled to receive this new license," stated S. Parikh Mars, CEO. "New York is the first of many licenses we hope to receive in the near future. We currently have applications pending in another 4 states and will be submitting more applications in the coming months. This is a significant step to expanding nationally and we believe that we will be able to see the results of our expansion before the end of the year."
About Progressive Care
Progressive Care, Inc. (OTC PINK: RXMD), through its subsidiary PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals specializing in health practice risk management, compounded medications, the sale of anti-retroviral medications and related medication therapy management, and the supply of prescription medications to long term care facilities.
Cautionary Statement Regarding Forward Looking Statements
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company's expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words "anticipate," "believe," "estimate," "upcoming," "plan," "target", "intend" and "expect" and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company's actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.
